Published in J Hematol Oncol on September 30, 2013
Novel ALK inhibitors in clinical use and development. J Hematol Oncol (2015) 1.24
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J Hematol Oncol (2015) 1.14
Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock (2015) 0.97
PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res (2015) 0.94
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy. J Hematol Oncol (2015) 0.94
Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab. J Hematol Oncol (2015) 0.93
Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade. J Hematol Oncol (2015) 0.91
Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors? J Hematol Oncol (2015) 0.90
PD-1 blockade enhances the vaccination-induced immune response in glioma. JCI Insight (2016) 0.90
Enhancement of the TCRζ expression, polyclonal expansion, and activation of t cells from patients with acute myeloid leukemia after IL-2, IL-7, and IL-12 induction. DNA Cell Biol (2015) 0.88
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol (2015) 0.86
The roles of stem cell memory T cells in hematological malignancies. J Hematol Oncol (2015) 0.85
PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells. Oncotarget (2016) 0.84
Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells. J Hematol Oncol (2015) 0.82
The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Exp Hematol Oncol (2015) 0.82
Control of local immunity by airway epithelial cells. Mucosal Immunol (2015) 0.81
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma. Mediterr J Hematol Infect Dis (2015) 0.81
Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia. Int J Mol Sci (2014) 0.81
Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas? Haematologica (2016) 0.75
Diagnosis and treatment of CD20 negative B cell lymphomas. Biomark Res (2017) 0.75
CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. Biomark Res (2014) 0.75
Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model. J Hematol Oncol (2015) 0.75
Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways. Sci Rep (2016) 0.75
Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade. Cell Discov (2017) 0.75
Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse. Int J Physiol Pathophysiol Pharmacol (2015) 0.75
The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1. Oncotarget (2017) 0.75
Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report. Oncol Lett (2016) 0.75
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling. PLoS One (2017) 0.75
Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer. Oncol Lett (2017) 0.75
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model. BMC Syst Biol (2017) 0.75
Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission. Front Immunol (2017) 0.75
The role of PD-1 in regulation of macrophage apoptosis and its subversion by Leishmania donovani. Clin Transl Immunology (2017) 0.75
Immunotherapy in Gastrointestinal Cancers. Biomed Res Int (2017) 0.75
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies. Onco Targets Ther (2017) 0.75
Driving better and safer HER2-specific CARs for cancer therapy. Oncotarget (2017) 0.75
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med (1999) 16.91
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J (1992) 8.86
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol (2004) 7.16
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80
PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol (2007) 6.24
Expression of programmed death 1 ligands by murine T cells and APC. J Immunol (2002) 5.78
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res (2008) 5.50
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol (2004) 4.58
Tumor immunotherapy directed at PD-1. N Engl J Med (2012) 4.43
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med (2003) 4.20
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res (2013) 3.48
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol (2003) 3.37
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood (2011) 3.18
PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med (2003) 3.05
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med (2003) 3.00
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett (2002) 2.80
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood (2009) 2.20
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood (2008) 2.15
Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin Cancer Res (2011) 2.05
Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics (1994) 1.96
Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res (1997) 1.85
Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol (1996) 1.68
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia (2008) 1.53
Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications. J Hematol Oncol (2011) 1.40
PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res (2011) 1.24
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica (2013) 1.21
PD-1/PD-L pathway and autoimmunity. Autoimmunity (2005) 1.09
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol (2000) 1.05
Structures of PD-1 with its ligands: sideways and dancing cheek to cheek. Proc Natl Acad Sci U S A (2008) 1.00
Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. Int J Cancer (2007) 0.99
Cellular immunotherapy for refractory hematological malignancies. J Transl Med (2013) 0.99
Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol Ther (2008) 0.99
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One (2013) 0.98
Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood (1999) 0.98
Therapeutic advancement of chronic lymphocytic leukemia. J Hematol Oncol (2012) 0.98
The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene (1997) 0.97
Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia. J Hematol Oncol (2012) 0.97
Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patients. J Transl Med (2010) 0.94
Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment. Oncoimmunology (2012) 0.93
Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML. Cancer Cell Int (2013) 0.90
IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors. Dev Comp Immunol (2007) 0.86
Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients. Hematology (2011) 0.86
PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal. J Clin Cell Immunol (2012) 0.85
Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. Br J Haematol (2003) 0.84
Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer. Oncoimmunology (2013) 0.83
Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population. Asia Pac J Clin Oncol (2012) 0.78
Progress, challenges, and opportunities in two-dimensional materials beyond graphene. ACS Nano (2013) 3.57
Two-dimensional phonon transport in supported graphene. Science (2010) 2.76
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine (2004) 2.72
A SIMULTANEOUS CONFIDENCE BAND FOR SPARSE LONGITUDINAL REGRESSION. Stat Sin (2012) 2.61
Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab (2009) 2.11
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci U S A (2006) 1.74
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60
IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. J Immunol (2005) 1.56
Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood (2006) 1.52
Middle and long-term clinical outcomes of patients with regional hepatolithiasis after subcutaneous tunnel and hepatocholangioplasty with utilization of the gallbladder. Hepatobiliary Pancreat Dis Int (2005) 1.47
Thermal transport in suspended and supported monolayer graphene grown by chemical vapor deposition. Nano Lett (2010) 1.44
Experimental murine cryptococcal infection results in contamination of bedding with Cryptococcus neoformans. Contemp Top Lab Anim Sci (2003) 1.40
Thermal conductance and thermopower of an individual single-wall carbon nanotube. Nano Lett (2005) 1.31
Varying coefficient model for gene-environment interaction: a non-linear look. Bioinformatics (2011) 1.29
FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci U S A (2008) 1.27
Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin. Proc Natl Acad Sci U S A (2004) 1.26
Antimicrobial preservative use in parenteral products: past and present. J Pharm Sci (2007) 1.25
Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells. BMC Cancer (2014) 1.23
Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia. J Hematol Oncol (2012) 1.23
Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J Control Release (2007) 1.20
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J Pharm Sci (2006) 1.15
Uniportal versus biportal video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis. Chin Med J (Engl) (2009) 1.13
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv (2010) 1.13
Ultrathin graphite foam: a three-dimensional conductive network for battery electrodes. Nano Lett (2012) 1.11
Isolation and culture of hair cell progenitors from postnatal rat cochleae. J Neurobiol (2005) 1.10
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS One (2010) 1.08
Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol (2005) 1.07
Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. Clin Vaccine Immunol (2007) 1.07
Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci U S A (2013) 1.06
Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients. Hematology (2011) 1.05
Determination of transport properties in chromium disilicide nanowires via combined thermoelectric and structural characterizations. Nano Lett (2007) 1.03
Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol (2010) 1.00
Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML. DNA Cell Biol (2012) 0.99
Thermal conductivity and phonon transport in suspended few-layer hexagonal boron nitride. Nano Lett (2013) 0.98
Genetic diversity of Mycobacterium tuberculosis isolates from Tibetans in Tibet, China. PLoS One (2012) 0.98
Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. J Pharm Sci (2006) 0.98
Raman measurements of thermal transport in suspended monolayer graphene of variable sizes in vacuum and gaseous environments. ACS Nano (2010) 0.97
Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia. J Hematol Oncol (2012) 0.97
Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Res (2004) 0.95
A transcontinental pilot study for acupuncture lifting-thrusting and twisting-rotating manipulations. Evid Based Complement Alternat Med (2012) 0.95
Gallus gallus aggrecan gene-based phylogenetic analysis of selected avian taxonomic groups. Genetica (2005) 0.94
Expression and distribution of PPP2R5C gene in leukemia. J Hematol Oncol (2011) 0.94
Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patients. J Transl Med (2010) 0.94
Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer. J Hematol Oncol (2011) 0.94
Significant electronic thermal transport in the conducting polymer poly(3,4-ethylenedioxythiophene). Adv Mater (2015) 0.94
TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transpl Immunol (2007) 0.93
Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa. Biochem Pharmacol (2003) 0.92
Profiling the thermoelectric power of semiconductor junctions with nanometer resolution. Science (2004) 0.92
The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology (2005) 0.92
Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles. Nanomedicine (2012) 0.92
Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. Hematology (2011) 0.92
Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell Int (2012) 0.91
Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS One (2011) 0.91
TCR zeta chain expression in T cells from patients with CML. Hematology (2009) 0.91
The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol Cancer (2013) 0.91
Reduced levels of recent thymic emigrants in acute myeloid leukemia patients. Cancer Immunol Immunother (2008) 0.90
Influence of polymeric residue on the thermal conductivity of suspended bilayer graphene. Nano Lett (2011) 0.90
Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML. Cancer Cell Int (2013) 0.90
Purification and characterization of a novel chlorpyrifos hydrolase from Cladosporium cladosporioides Hu-01. PLoS One (2012) 0.90
Similarities and differences in aspirated tracheobronchial foreign bodies in patients under the age of 3 years. Int J Pediatr Otorhinolaryngol (2012) 0.90
Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells. DNA Cell Biol (2013) 0.89
Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. Hematology (2011) 0.88
Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors. J Control Release (2009) 0.88
A mathematical model for simulating the bone remodeling process under mechanical stimulus. Dent Mater (2006) 0.88
Meta-analysis of ALDH2 variants and esophageal cancer in Asians. Asian Pac J Cancer Prev (2011) 0.88
Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation. J Hematol Oncol (2013) 0.88
The role of BCL11B in regulating the proliferation of human naive T cells. Hum Immunol (2012) 0.88
Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease. Clin Res Cardiol (2009) 0.87
Evaluation of the thermal stability of Gardasil. Hum Vaccin (2006) 0.87
TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood. Transpl Immunol (2008) 0.87
Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. J Hematol Oncol (2010) 0.86
Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia. Hematology (2012) 0.86
Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients. Hematology (2011) 0.86
Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia. Hum Immunol (2011) 0.86
The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations. Diabetes Metab Res Rev (2012) 0.86
Role of p63/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposis. J Allergy Clin Immunol (2011) 0.86